Boeing layoffs: Which department will be affected and why will it cut 5% of its workforce? Here's what we know
Boeing will eliminate the posts through a mix of layoffs and attrition. The reason is because of a slower ramp-up to 'provide our factories and supply chain partners additional time to achieve stability,' said a message to employees from Stephanie Pope. The development comes just two weeks after Boeing said it was delaying plans to increase production of its 737 Max narrowbody jet into 2027.
Read full articleMORE NEWS
$57.2 billion Treasury cash drain hits Wall Street this week: Why semiconductor stocks and SMH ETF investors face more volatility, with a bigger liquidity test coming in 2027
Upcoming Treasury bill settlements on November 10 and 12 are expected to withdraw $57.2 billion from markets. The VanEck Semiconductor ETF has already experienced a notable decline since October, losing nearly 25 percent of its value. Historical trading data indicates that semiconductor stocks perform better when Treasury bill issuance is lower. A potential easing of liquidity pressure may occur in December due to reduced auction sizes.
Between the chip and the slip: Honeytrap suspicions further sours ties between US and China
Nvidia's CEO Jensen Huang is being investigated for having an alleged affair with a potential Chinese intelligence agent. This individual reportedly sought to gather information about Nvidia's advanced technology. Nvidia's board has launched an independent probe to examine the allegations against Huang. US lawmakers are demanding a briefing on the matter amid heightened concerns over national security.
Russia-Ukraine peace talks: In Abu Dhabi, US to look for security guarantees for both
The talks follow last month's localized truce around the Russian-occupied city of Oleshky in southern Ukraine that was brokered with the help of US first lady Melania Trump and allowed the evacuation of some of its residents and the delivery of desperately needed humanitarian supplies.
Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDA
Eli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (US FDA).
